The Egyptian pharmaceutical industry has announced plans to maintain current drug prices until the end of 2026. According to Dr. Ali Auf, head of the Drug Division at the General Federation of Egyptian Chambers of Commerce, the industry aims to provide stability in the market and allow companies and citizens to plan accordingly. This move is expected to bring relief to patients and citizens who rely on affordable medication.
The pricing of drugs in Egypt is based on a controlled pricing system, which takes into account the cost of production and the need for a reasonable profit margin for companies. Dr. Auf emphasized that any potential price increase would be linked to changes in the exchange rate, as fluctuations in the dollar's value can significantly impact the cost of importing raw materials and producing medication.
The review of drug prices is carried out through official procedures and based on a study of production costs and industry-related variables. The goal is to strike a balance between the sustainability of the pharmaceutical industry and the ability of citizens to access the medication they need. This approach aims to ensure that the industry remains viable while also protecting the interests of patients.
Dr. Mahfouz Ramzi, head of the Pharmaceutical Manufacturing Committee at the Egyptian Pharmacists' Syndicate, noted that drugs for chronic diseases have been less affected by price increases. He emphasized that the government is committed to ensuring the availability of these medications, particularly those used to treat conditions such as hypertension and diabetes, at affordable prices.
The stability of drug prices is crucial for patients who rely on medication to manage chronic conditions. The government's efforts to maintain affordable prices and ensure the availability of essential medications are expected to have a positive impact on public health. The pharmaceutical industry is also working to keep pace with modern developments in the field, in line with international standards and regulations.
Egypt's pharmaceutical industry is working to localize the production of raw materials, with a goal of producing 50 key ingredients domestically. This initiative aims to reduce reliance on imports and make the industry more self-sufficient. By investing in local production, the industry can better manage costs and maintain stability in the market.
The decision to freeze drug prices until the end of 2026 is expected to provide relief to patients and citizens. Three key points emerge from this development: the stability of drug prices, the potential for price increases tied to exchange rate fluctuations, and the government's commitment to ensuring the availability of essential medications at affordable prices. KEY_POINT: The Egyptian government has announced plans to maintain current drug prices until the end of 2026. KEY_POINT: The pricing of drugs in Egypt is based on a controlled pricing system. KEY_POINT: The industry is working to localize the production of raw materials to reduce reliance on imports.
